1. Home
  2. VNRX vs APT Comparison

VNRX vs APT Comparison

Compare VNRX & APT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VNRX
  • APT
  • Stock Information
  • Founded
  • VNRX N/A
  • APT 1983
  • Country
  • VNRX United States
  • APT Canada
  • Employees
  • VNRX N/A
  • APT N/A
  • Industry
  • VNRX Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • APT
  • Sector
  • VNRX Health Care
  • APT
  • Exchange
  • VNRX Nasdaq
  • APT Nasdaq
  • Market Cap
  • VNRX 52.4M
  • APT 50.5M
  • IPO Year
  • VNRX N/A
  • APT 1995
  • Fundamental
  • Price
  • VNRX $0.80
  • APT $4.70
  • Analyst Decision
  • VNRX Strong Buy
  • APT
  • Analyst Count
  • VNRX 5
  • APT 0
  • Target Price
  • VNRX $3.88
  • APT N/A
  • AVG Volume (30 Days)
  • VNRX 307.1K
  • APT 37.7K
  • Earning Date
  • VNRX 08-13-2025
  • APT 08-06-2025
  • Dividend Yield
  • VNRX N/A
  • APT N/A
  • EPS Growth
  • VNRX N/A
  • APT 2.28
  • EPS
  • VNRX N/A
  • APT 0.36
  • Revenue
  • VNRX $1,308,361.00
  • APT $58,180,000.00
  • Revenue This Year
  • VNRX $563.72
  • APT N/A
  • Revenue Next Year
  • VNRX $160.43
  • APT N/A
  • P/E Ratio
  • VNRX N/A
  • APT $12.73
  • Revenue Growth
  • VNRX 64.16
  • APT N/A
  • 52 Week Low
  • VNRX $0.40
  • APT $4.06
  • 52 Week High
  • VNRX $0.94
  • APT $6.44
  • Technical
  • Relative Strength Index (RSI)
  • VNRX 75.61
  • APT 54.21
  • Support Level
  • VNRX $0.40
  • APT $4.54
  • Resistance Level
  • VNRX $0.75
  • APT $4.72
  • Average True Range (ATR)
  • VNRX 0.08
  • APT 0.21
  • MACD
  • VNRX 0.02
  • APT -0.01
  • Stochastic Oscillator
  • VNRX 69.33
  • APT 35.21

About VNRX VolitionRX Limited

VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.

About APT Alpha Pro Tech Ltd.

Alpha Pro Tech Ltd is in the business of protecting people, products and environments. It is developing, manufacturing and marketing a line of disposable protective apparel and infection control products for the cleanroom, industrial, pharmaceutical, medical and dental markets. It also manufacture a line of building supply construction weatherization products that are sold under the Alpha Pro Tech brand name. The Company operates through two business segments: Building Supply and Disposable Protective Apparel. Key revenue is generated from Building Supply: consisting of a line of construction supply weatherization products. The construction supply weatherization products consist of housewrap and synthetic roof underlayment and synthetic roof underlayment accessories.

Share on Social Networks: